Premium Market Analysis, Trader Education, Software, and Trading Strategies. Thirty Years Of Skin In The Game

Premium Signals

Market Signals For November 11, 2024

Market recap, open positions, new signals, and performance of six trading strategies. Tactical asset allocation, mean reversion, cross-sectional momentum, and equity long-short with weekly and monthly updating. Access the full report with a Market Signals or All-in-One subscription.

Contents

1. Performance of the Ensemble and Benchmarks
2. Recap and Comments
3. Positions and Performance of Strategies
4. Signal Summary for Next Week

1. Performance of the ensemble and benchmarks

Weekly return of the ensemble: 2%

blank

This week, the equity of the equally weighted strategy ensemble gained 2%.

Year-to-date performance (Backtest, no leverage)

YTD Return YTD Maximum Drawdown Weekly Change
Strategy ensemble +14.4% -2.5% +2.0%
Invesco RSP ETF +18.1% -5.6% +4.4%
SPDR SPY ETF +27.0% -5.4% +4.8%

On a risk-adjusted basis, the ensemble outperforms both the SPY ETF and its equal-weight counterpart, the RSP ETF.

2. Recap and Comments (November 4–November 8, 2024)

Update: As of Friday, November 8, 2024, Nvidia (NVDA) and Sherwin-Williams (SHW) replaced Intel Corp. (INTC) and Dow Inc. (DOW) in the Dow-30 index. The two strategies that generate signals for Dow-30 stocks, MRDOWW and DOWWN, now account for these changes.

All strategies experienced gains this week, with the exception of the Dow-30 long-short strategy. The average gain of the six strategies was 2%.

As already mentioned last week, we are thinking of replacing the strategies that generate signals for stocks next year with ones that use ETFs only. Company-specific risks are increasing in a fast-moving tech world. In fact, the inclusion of NVDA in the Dow-30 reinforces this view. Another alternative could be focusing only on low-beta stocks. We will announce the decision next month.

The objective of the strategy ensemble is to generate reasonable returns in a “comfortable” risk zone. There is potential for generating alpha from leveraged beta, but this is not a strategy we favor. We believe that leverage is suitable only for professional traders, not those who are looking for reasonable risk-adjusted returns. However, opinions on the subject vary.

The ensemble includes a long-short strategy for Dow-30 stocks that fell this week. Note that this is normal behavior. When there are strong upside reversals or rallies in the market, short positions lose more than long positions gain. Why is this strategy included in the ensemble? Although it may seem counterintuitive, a long-short strategy, due to its low beta with the market, smooths returns. For example, during fast crashes, the long-short strategy usually outperforms and may provide a solid hedge, which helps limit drawdowns and equity volatility.

Nevertheless, subscribers have the choice to ignore the long-short strategy and focus only on a set of strategies they feel align with their objectives.

3. Positions and strategy performance: Friday, November 8, 2024

This post is for paid subscribers

 

 

Already a subscriber? Sign in


Access the full report with a Market Signals or All-in-One subscription. By subscribing, you have immediate access to hundreds of articles. Market Signals subscribers have immediate access to hybrid asset allocation and dynamic momentum monthly signals and more than two hundred articles in the Premium Education section, and All in One subscribers have access to all premium content (except daily mean-reversion signals.)

Charting and backtesting program: Amibroker. Data provider: Norgate Data

Disclaimer: The Premium and Weekly Signals are provided for informational purposes only and do not constitute investment advice or actionable content. We do not warrant the accuracy, completeness, fitness, or timeliness for any particular purposes of the Premium and Weekly Signals. Under no circumstances should the premium or weekly signals be treated as financial advice. The author of this website is not a registered financial adviser. Before subscribing, please read our Disclaimer and Terms and Conditions.

Copyright notice: Any unauthorized copy, reproduction, distribution, publication, display, modification, or transmission of any part of this report is strictly prohibited without prior written permission.